CClinicalTrials.gg
CompletedNCT04625634Updated Jul 26, 2022

Simulation of Consecutive Day Shift Work

An interventional study of 2 days of work heat stress in Hyperthermia and Fatigue; Heat, sponsored by State University of New York at Buffalo. Completed at 1 site in United States. Open to participants aged 18 Years to 39 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-07-26.

Sponsored by State University of New York at Buffalo · Not applicable, Interventional, and Other

From the registry’s dates

  • Registered 11 months after the study started (first participant enrolled Dec 2019, registered Nov 2020).
Phase
Not applicable
Study type
Interventional
Enrollment
23
Allocation
Not applicable
Ages
18 Years to 39 Years
Sex
All
01

Study summary

The purpose of this study is to determine differences in physiological recovery between two consecutive days of simulated fire suppression work. The secondary purpose is to determine differences in heat gain and heat loss between two consecutive days of simulated fire suppression work. Subjects will complete two consecutive days of simulated structural firefighting shift work, 24 hours apart. Before and after each laboratory visit, subjects will continuously wear a Holter monitor and ambulatory blood pressure monitor to quantify parasympathetic tone and recovery from work.

02

Conditions studied

  • Hyperthermia
  • Fatigue; Heat

Browse trials for

03

In context

Hyperthermia

478 studies on the registry are indexed under Hyperthermia; 92 are open to participants now.

This study's enrollment of 23 is below the median of 60 across 365 interventional studies indexed under Hyperthermia.

Browse Hyperthermia studies →

Lead sponsor

State University of New York at Buffalo is the lead sponsor of 287 studies on the registry; 65 are open to participants now.

Of its 19 completed or terminated interventional studies of FDA-regulated products, 15 (79%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 39 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • 18-39 y old men and women
  • Self-reported to be healthy

Exclusion criteria

Exclusion Criteria:

  • History of any cardiovascular, neurologic, renal, or metabolic disease
  • Current tobacco use or regular use within the last 2 years
  • Taking medications with known thermoregulatory or cardiovascular effects (e.g., aspirin, acetaminophen, ibuprofen, beta blockers, diuretics, psychotropics, etc.)
  • History of exertional heat stroke
  • Currently pregnant or breastfeeding, or planning to become pregnant during the study
  • Inability to follow the rules of the protocols or understand the consent form
  • No contraindications for ingestion of the gastrointestinal temperature pill
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
23 participants (actual)

Study arms

  • Experimental
    Consecutive work

    Subjects will complete 2 consecutive days of simulated firefighting tasks in the heat. The simulated work consists of 20 minutes of simulated structural work in a hot environment, followed by 20 minutes of seated rest in a temperate room, mimicking a typical recovery period in structural firefighting. Subjects then re-enter the environmental chamber and complete 23 minutes of simulated overhaul work in a temperate environment.

    Other: 2 days of work heat stress

Interventions

  • Other2 days of work heat stress

    2 consecutive days of identical simulated structural firefighting tasks.

06

What researchers measure

Primary outcomes

  1. Core temperature

    Gastrointestinal temperature measured with an ingestable pill.

    Time frame: 20 minutes

  2. Heart rate

    Heart rate measured with a wearable heart rate strap and monitor

    Time frame: 20 minutes

07

Study locations

1 site
  • Center for Research and Exercise in Special Environments
    Buffalo, New York 14214, United States
08

References and documents

Individual participant data

Plan to share: No — Individual data can be made available upon written request.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 26, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04625634
Lead sponsor
State University of New York at Buffalo
Responsible party
Riana Pryor (Primary Investigator, State University of New York at Buffalo) — Principal investigator
First posted
Nov 12, 2020
Start date
Dec 2, 2019
Primary completion
May 1, 2022
Completion
May 1, 2022
Last update
Jul 26, 2022

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion